Cogmotos
  • Cogmotos
    • About Cogmotos
    • Meet the Team
  • The Problem
    • Post Operative Delirium
    • POC: Insulin
    • POD: Pharmacoeconomics
  • Our Technology
    • The BBB
    • Direct to the Brain
  • Contact Us

Neuro/Vascular Platform with Clinical Proof of Concept in Postoperative Delirium

Translating clinically-proven biology from three continents into commercialized treatments for high-impact neurological disorders

Cogmotos holds exclusive rights to a US patent for treating POD with intranasal insulin and has patented technology for intranasal drug delivery to the brain

Developing a groundbreaking treatment for postoperative delirium

Welcome to the Cogmotos, we are focused on developing a groundbreaking treatment for postoperative delirium. Cogmotos aims to tackle this issue by using cutting-edge technology to deliver treatment directly to the brain. We are currently in the process of developing a treatment for postoperative delirium, a condition that affects millions of patients each year. We are also working on developing treatments for other cognitive disorders, such as Alzheimer’s disease and dementia.

Latest content

Tackling Post Operative Delerium (POD)
Postoperative delirium; largest unaddressed disorder of aging

Overcoming the Blood-Brain Barrier: Challenges for Drug Delivery
Imagine your brain as a VIP party venue, where only the most important guests are allowed entry. Well, the blood-brain barrier acts as the bouncer…

Insulin: Proof of Concept (POC)


While insulin widely known is a hormone that plays a crucial role in regulating blood sugar levels, it plays a…
No matching items

The Blood Brain Barrier

Read about the Blood Brain Barrier and how it affects drug delivery

Read More Here

Learning

Postoperative Delirium: The unmet need

Learn More

Published by

About us

Our Aims
Our Team
Contact Us

Contact Us

For more information

Follow Us

LinkedIn

Copyright © 2023 Cogmotos, Inc.
Cookie Preferences
Terms & Conditions